Fertility warning
This medicine may affect fertility.
Leaflet TEMOZOLOMIDE HEXAL 180mg capsules
- Product code:
- W55514004
- Quantity:
- 20
- Indicated for:
- malignant glioma
- Route of administration:
- oral
- Substance:
- temozolomide (alkylating antineoplastic agent)
- ATC
- L01AX03 — Antineoplastic and immunomodulating agents | Alkylating agents | Other alkylating agents
Precautions:
Dose adjustment in hepatic impairment
Dose adjustment may be needed in liver disease.
Cytotoxic / special handling
Handle with special care.
Contraception required
Effective contraception is required during treatment.
Contraindicated during breastfeeding
Do not use this medicine while breastfeeding.
Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Hepatotoxicity
This medicine may affect the liver.
Major drug interactions
This medicine may have important interactions with other medicines.
Myelosuppression / agranulocytosis
This medicine may lower blood cell counts.
Additional monitoring
This medicine is subject to additional monitoring.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Severe skin reactions
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Temozolomide is a chemotherapy agent used for the treatment of certain types of brain tumors, such as glioblastoma multiforme and anaplastic astrocytoma. It works by interfering with the DNA of tumor cells, thereby inhibiting their growth and division.
The medication is taken orally, usually once daily, as directed by a doctor. The dosage is adjusted based on body weight and the patient's overall condition.
Patients should be monitored for potential side effects, such as nausea, vomiting, or a decrease in blood cell counts. It is important to inform the doctor of any unusual symptoms.
Common side effects include nausea, vomiting, fatigue, and loss of appetite. In rare cases, severe reactions such as myelosuppression or serious infections may occur. Patients should be informed of these risks before starting treatment.
The medication is taken orally, usually once daily, as directed by a doctor. The dosage is adjusted based on body weight and the patient's overall condition.
Patients should be monitored for potential side effects, such as nausea, vomiting, or a decrease in blood cell counts. It is important to inform the doctor of any unusual symptoms.
Common side effects include nausea, vomiting, fatigue, and loss of appetite. In rare cases, severe reactions such as myelosuppression or serious infections may occur. Patients should be informed of these risks before starting treatment.
General data about TEMOZOLOMIDE HEXAL 180mg
- Substance:
- temozolomide
- Date of latest medicines list:
- 01-07-2013
- Product code:
- W55514004
- Concentration:
- 180mg
- Pharmaceutical form:
- capsules
- Quantity:
- 20
- Product type:
- Generic medicine
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for temozolomide
Concentrations available for temozolomide
- 100mg
- 140mg
- 180mg
- 2.5mg/ml
- 20mg
- 240mg
- 250mg
- 5mg